| Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in … N Vidal, M Peeters, C Mulanga-Kabeya, N Nzilambi, D Robertson, ... Journal of virology 74 (22), 10498-10507, 2000 | 406 | 2000 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 333 | 2019 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K K Triques, A Bourgeois, N Vidal, E Mpoudi-Ngole, C Mulanga-Kabeya, ... AIDS research and human retroviruses 16 (2), 139-151, 2000 | 179 | 2000 |
| Specific polymerase chain reaction diagnosis P Kengne, F Veas, N Vidal, JL Rey, G CUNY Cellular and molecular biology 40 (6), 819-831, 1994 | 178 | 1994 |
| Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks AK Keita, FR Koundouno, M Faye, A Düx, J Hinzmann, H Diallo, ... Nature 597 (7877), 539-543, 2021 | 148 | 2021 |
| Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form AB Abecasis, P Lemey, N Vidal, T de Oliveira, M Peeters, R Camacho, ... Journal of virology 81 (16), 8543-8551, 2007 | 129 | 2007 |
| Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation F Gao, N Vidal, Y Li, SA Trask, Y Chen, LG Kostrikis, DD Ho, J Kim, ... AIDS research and human retroviruses 17 (8), 675-688, 2001 | 126 | 2001 |
| Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open … A Calmy, TT Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, ... The lancet HIV 7 (10), e677-e687, 2020 | 114 | 2020 |
| The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness HF Njai, Y Gali, G Vanham, C Clybergh, W Jennes, N Vidal, C Butel, ... Retrovirology 3, 1-11, 2006 | 109 | 2006 |
| High diversity of HIV-1 subtype F strains in Central Africa K Triques, A Bourgeois, S Saragosti, N Vidal, E Mpoudi-Ngole, ... Virology 259 (1), 99-109, 1999 | 104 | 1999 |
| High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo M Salou, AY Dagnra, C Butel, N Vidal, L Serrano, E Takassi, AA Konou, ... Journal of the International AIDS Society 19 (1), 20683, 2016 | 96 | 2016 |
| Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002 N Vidal, C Mulanga, SE Bazepeo, JK Mwamba, JW Tshimpaka, M Kashi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (4), 456-462, 2005 | 95 | 2005 |
| Survey of Ebola viruses in frugivorous and insectivorous bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017 HM De Nys, PM Kingebeni, AK Keita, C Butel, G Thaurignac, ... Emerging infectious diseases 24 (12), 2228, 2018 | 87 | 2018 |
| Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment P Mbala-Kingebeni, A Aziza, N Di Paola, MR Wiley, S Makiala-Mandanda, ... The Lancet infectious diseases 19 (6), 648-657, 2019 | 83 | 2019 |
| Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV A Ayouba, G Thaurignac, D Morquin, E Tuaillon, R Raulino, A Nkuba, ... Journal of Clinical Virology 129, 104521, 2020 | 79 | 2020 |
| High prevalence of HIV‐1 drug resistance among patients on first‐line antiretroviral treatment in Lome, Togo AY Dagnra, N Vidal, A Mensah, A Patassi, K Aho, M Salou, M Monleau, ... Journal of the International AIDS Society 14 (1), 30-30, 2011 | 70 | 2011 |
| Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ... The Lancet HIV 7 (11), e772-e781, 2020 | 66 | 2020 |
| Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort P De Beaudrap, M Thiam, A Diouf, C Toure-Kane, NF Ngom-Guèye, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (4), 381-387, 2013 | 60 | 2013 |
| HIV-1 subtypes and recombinants in the Republic of Congo FR Niama, C Toure-Kane, N Vidal, P Obengui, B Bikandou, MYN Nkodia, ... Infection, Genetics and Evolution 6 (5), 337-343, 2006 | 60 | 2006 |
